We deliver solutions through our focus on improving established oncological products and developing innovative synergistic novel medicines. We focus on improving the lives of patients with rare cancers with serious or clinically meaningful unmet needs. Please contact us about a potential business development or collaboration opportunity at:


Presentation Doc


1:1 Investor and Analyst Meetings

New York – July 23 & 31, 2019